These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. A study of a family with the skeletal muscle RYR1 mutation (c.7354C>T) associated with central core myopathy and malignant hyperthermia susceptibility. Taylor A; Lachlan K; Manners RM; Lotery AJ J Clin Neurosci; 2012 Jan; 19(1):65-70. PubMed ID: 22030266 [TBL] [Abstract][Full Text] [Related]
27. Exome sequencing: one small step for malignant hyperthermia, one giant step for our specialty--why exome sequencing matters to all of us, not just the experts. Nagele P Anesthesiology; 2013 Nov; 119(5):1006-8. PubMed ID: 24195944 [No Abstract] [Full Text] [Related]
28. Confirmation of nonanesthetic-induced malignant hyperthermia. Larach MG; Allen GC; Rosenberg H Anesthesiology; 2012 Jun; 116(6):1398-9; author reply 1399-400. PubMed ID: 22617205 [No Abstract] [Full Text] [Related]
29. Identification of a novel mutation in the ryanodine receptor gene (RYR1) in patients with malignant hyperthermia. Rueffert H; Kraus H; Olthoff D; Deutrich C; Froster UG Hum Mutat; 2001 Mar; 17(3):238. PubMed ID: 11241852 [No Abstract] [Full Text] [Related]
30. The genetics of malignant hyperthermia. Brandom BW Anesthesiol Clin North Am; 2005 Dec; 23(4):615-9, viii. PubMed ID: 16310654 [TBL] [Abstract][Full Text] [Related]
31. A rare genetic variant of the ryanodine receptor in a suspected malignant hyperthermia susceptible patient. MacKay EJ; Wilkerson C; Kraeva N; Rosenberg H; Kennedy T J Clin Anesth; 2016 Sep; 33():144-6. PubMed ID: 27555149 [TBL] [Abstract][Full Text] [Related]
32. XXIVth Annual Meeting of the European Malignant Hyperthermia Group. Brandom BW; Muldoon SM Anesthesiology; 2005 Dec; 103(6):1324. PubMed ID: 16306761 [No Abstract] [Full Text] [Related]
33. Continued progress in understanding the molecular genetics of malignant hyperthermia. Rosenberg H Can J Anaesth; 2011 Jun; 58(6):489-93. PubMed ID: 21455644 [No Abstract] [Full Text] [Related]
34. Ryanodine receptor type 1 gene mutations found in the Canadian malignant hyperthermia population. Kraeva N; Riazi S; Loke J; Frodis W; Crossan ML; Nolan K; Kraev A; Maclennan DH Can J Anaesth; 2011 Jun; 58(6):504-13. PubMed ID: 21455645 [TBL] [Abstract][Full Text] [Related]
35. Malignant hyperthermia associated with exercise-induced rhabdomyolysis or congenital abnormalities and a novel RYR1 mutation in New Zealand and Australian pedigrees. Davis M; Brown R; Dickson A; Horton H; James D; Laing N; Marston R; Norgate M; Perlman D; Pollock N; Stowell K Br J Anaesth; 2002 Apr; 88(4):508-15. PubMed ID: 12066726 [TBL] [Abstract][Full Text] [Related]